Product
Paclitaxel + Cisplatin + Cadonilimab
1 clinical trial
2 indications
Indication
Esophageal Squamous Cell CarcinomaIndication
Neoadjuvant TherapyClinical trial
A Clinical Study on the Efficacy and Safety of Paclitaxel Polymer Micelles and Cisplatin Combined With Cadonilimab as a Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma：A Single Arm, Single Center, Prospective Clinical Trial (POINTS Trial)Status: Not yet recruiting, Estimated PCD: 2025-04-20